These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18442962)

  • 1. Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot.
    Witte KK; Pepper CB; Cowan JC; Thomson JD; English KM; Blackburn ME
    Europace; 2008 Aug; 10(8):926-30. PubMed ID: 18442962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry.
    Waldmann V; Bouzeman A; Duthoit G; Koutbi L; Bessiere F; Labombarda F; Marquié C; Gourraud JB; Mondoly P; Sellal JM; Bordachar P; Hermida A; Anselme F; Asselin A; Audinet C; Bernard Y; Boveda S; Bru P; Bun SS; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Garcia R; Guenancia C; Guy-Moyat B; Halimi F; Irles D; Iserin L; Jourda F; Ladouceur M; Lagrange P; Laredo M; Mansourati J; Massoulié G; Mathiron A; Maury P; Messali A; Narayanan K; Nguyen C; Ninni S; Perier MC; Pierre B; Pujadas P; Sacher F; Sagnol P; Sharifzadehgan A; Walton C; Winum P; Zakine C; Fauchier L; Martins R; Pasquié JL; Thambo JB; Jouven X; Combes N; Marijon E;
    Circulation; 2020 Oct; 142(17):1612-1622. PubMed ID: 32998542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in tetralogy of Fallot.
    Khairy P; Harris L; Landzberg MJ; Viswanathan S; Barlow A; Gatzoulis MA; Fernandes SM; Beauchesne L; Therrien J; Chetaille P; Gordon E; Vonder Muhll I; Cecchin F
    Circulation; 2008 Jan; 117(3):363-70. PubMed ID: 18172030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot.
    Koyak Z; de Groot JR; Bouma BJ; Van Gelder IC; Budts W; Zwinderman AH; Mulder BJ
    Int J Cardiol; 2013 Aug; 167(4):1532-5. PubMed ID: 22608897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators.
    Waldmann V; Bouzeman A; Duthoit G; Koutbi L; Bessière F; Labombarda F; Marquié C; Gourraud JB; Mondoly P; Sellal JM; Bordachar P; Hermida A; Al Arnaout A; Anselme F; Audinet C; Bernard Y; Boveda S; Bun SS; Chassignolle M; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Garcia R; Guenancia C; Guy-Moyat B; Halimi F; Irles D; Iserin L; Jourda F; Ladouceur M; Lagrange P; Laredo M; Mansourati J; Massoulié G; Mathiron A; Maury P; Messali A; Narayanan K; Nguyen C; Ninni S; Perier MC; Pierre B; Pujadas P; Sacher F; Sagnol P; Sharifzadehgan A; Walton C; Winum P; Zakine C; Fauchier L; Martins R; Pasquié JL; Thambo JB; Jouven X; Combes N; Marijon E
    JACC Clin Electrophysiol; 2022 Oct; 8(10):1304-1314. PubMed ID: 36266008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot topics in tetralogy of Fallot.
    Villafañe J; Feinstein JA; Jenkins KJ; Vincent RN; Walsh EP; Dubin AM; Geva T; Towbin JA; Cohen MS; Fraser C; Dearani J; Rosenthal D; Kaufman B; Graham TP;
    J Am Coll Cardiol; 2013 Dec; 62(23):2155-66. PubMed ID: 24076489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator therapy in repaired tetralogy of Fallot after pulmonary valve replacement: Implications for the mechanism of ventricular arrhythmia.
    Chiu SN; Huang SC; Wang JK; Lu CW; Chang LY; Lin MT; Chen CA; Chen YS; Wu MH
    Int J Cardiol; 2017 Dec; 249():156-160. PubMed ID: 29121719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Efficacy of Implantable Cardioverter Defibrillator in Repaired Tetralogy of Fallot　- Role of Anti-tachycardia Pacing.
    Henmi R; Ejima K; Yagishita D; Iwanami Y; Nishimura T; Takeuchi D; Toyohara K; Shoda M; Hagiwara N
    Circ J; 2017 Jan; 81(2):165-171. PubMed ID: 27941299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
    Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator.
    Bessière F; Gardey K; Bouzeman A; Duthoit G; Koutbi L; Labombarda F; Marquié C; Gourraud JB; Mondoly P; Sellal JM; Bordachar P; Hermida A; Anselme F; Asselin A; Audinet C; Bernard Y; Boveda S; Chevalier P; Clerici G; da Costa A; de Guillebon M; Defaye P; Eschalier R; Garcia R; Guenancia C; Guy-Moyat B; Henaine R; Irles D; Iserin L; Jourda F; Ladouceur M; Lagrange P; Laredo M; Mansourati J; Massoulié G; Mathiron A; Maury P; Nguyen C; Ninni S; Perier MC; Pierre B; Sacher F; Walton C; Winum P; Martins R; Pasquié JL; Thambo JB; Jouven X; Combes N; Di Filippo S; Marijon E; Waldmann V
    JACC Clin Electrophysiol; 2021 Oct; 7(10):1285-1293. PubMed ID: 33933408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillators in patients with valvular cardiomyopathy.
    Valles AG; Khawaja FJ; Gersh BJ; Enriquez-Sarano M; Friedman PA; Park SJ; Hodge DO; Cha YM
    J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1326-32. PubMed ID: 23130974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry.
    Laredo M; Duthoit G; Sacher F; Anselme F; Audinet C; Bessière F; Bordachar P; Bouzeman A; Boveda S; Bun SS; Chassignolle M; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Extramiana F; Fauchier L; Hermida A; Gandjbakhch E; Garcia R; Gourraud JB; Guenancia C; Guy-Moyat B; Irles D; Iserin L; Jourda F; Koutbi L; Labombarda F; Ladouceur M; Lagrange P; Lellouche N; Mansourati J; Marquié C; Martins R; Massoulié G; Mathiron A; Maury P; Messali A; Milhem A; Mondoly P; Nguyen C; Ninni S; Pasquié JL; Pierre B; Pujadas P; Sellal JM; Thambo JB; Walton C; Winum P; Zakine C; Zhao A; Jouven X; Combes N; Marijon E; Waldmann V;
    Heart Rhythm; 2023 Feb; 20(2):252-260. PubMed ID: 36309156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in surgically repaired tetralogy of Fallot.
    Khairy P; Dore A; Poirier N; Marcotte F; Ibrahim R; Mongeon FP; Mercier LA
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):755-62. PubMed ID: 19589112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic implantable defibrillators in dilated cardiomyopathy.
    Grimm W
    Herz; 2012 Dec; 37(8):859-66. PubMed ID: 23052902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of sudden cardiac death in patients with Tetralogy of Fallot: Risk assessment and long term outcome.
    Probst J; Diller GP; Reinecke H; Leitz P; Frommeyer G; Orwat S; Vormbrock J; Radke R; de Torres Alba F; Kaleschke G; Baumgartner H; Eckardt L; Wasmer K
    Int J Cardiol; 2018 Oct; 269():91-96. PubMed ID: 29980366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate implantable cardioverter-defibrillator shocks in repaired tetralogy of fallot patients: Prevalence and electrophysiological mechanisms.
    L Goldenthal I; Rosenbaum MS; Lewis M; Sciacca RR; Garan H; Biviano AB
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100543. PubMed ID: 32490149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.